Seeks to exempt central excise duty on the scheduled formulations as defined under the Drugs Price Control Order (DPCO), 2013 and which are subjected to re-printing, re-labeling, re-packing or stickering, in pursuance of the provisions contained in the said Order, in a premises which is not registered under the Central Excise Act, 1944 or the rules made thereunder
Show AI Summary
Excise duty exemption for DPCO scheduled formulations undergoing re-labeling when MRP reduced, subject to prior intimation and post-operation reporting.
Exempts from central excise duty scheduled formulations under DPCO, 2013 (Chapter 30) when re-printing, re-labeling, re-packing or stickering is carried out at premises not registered under the Central Excise Act, subject to conditions: removal on payment of appropriate duty, downward revision of MRP, a time-limited exemption from NPPA ceiling-price notification (with limited extension), prior intimation to the jurisdictional Assistant/Deputy Commissioner with specified product and location details, and submission of post-operation details within one month.